Bacillus Calmette-Guerin-induced interleukin-10 inhibits S100A8/A9 production and hinders development of T helper type 1 memory in mice

Yaping Wang,Yuehua Sun,Yong Zheng,Yuling Yang,Liu He,Peijie Qu,Fangting Zhou,XiaoXu Xu,Xuanchang Bai,Xin Chen,Yangxuan Yuan,Min Liu,Qin Pan
DOI: https://doi.org/10.1002/eji.202250204
2023-01-01
European Journal of Immunology
Abstract:Tuberculosis caused by Mycobacterium tuberculosis (M.tb) is one of the main causes of human death in the world. Bacillus Calmette-Guerin (BCG) provides limited protection in adolescents and adults. To explore the factors reducing efficacy of BCG vaccine, we assess the impacts of interleukin (IL)-10 and alarmins S100A8/A9 on T-cell memory. We found that BCG-induced IL-10 inhibited production of S100A8/A9 in human peripheral blood mononuclear cells (PBMCs) and murine splenocytes. S100A9 deficiency inhibited IFN-gamma production by CD4(+) T cells in the early phase of BCG immunization and hindered the development of effector memory T helper type 1 (Th1) cells, while IL-10 deficiency promoted Th1 memory and blocking IL-10 signaling enhanced Th1 protective recall response against M.tb. IL-10 inhibited the binding of transcription factor CCAAT enhancer binding protein beta to S100a8/a9 promoter leading to S100A8/A9 reduction. S100A8/A9 heterodimer enhanced the IFN-gamma production via receptor for advanced glycation end products signaling in CD4(+) T cells. Our results demonstrate a hurdle to development of Th1 memory after BCG immunization and clarify the mechanism of the regulation of Th1 memory by IL-10 and S100A8/A9.
What problem does this paper attempt to address?